TickerFacts.

Company research / PLRZ

Polyrizon Ltd. (PLRZ)

Build a valuation ↗↓ Download CSV

CIK 0001893645 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Fiscal year ends Dec 31

Key ratios (year ended 2025-12-31)

-15.9%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-31
R&D Expense$2.13M$534.0K$332.0K$347.0K
Operating Income-$6.25M-$1.30M-$635.0K-$895.0K
Net Income-$3.33M-$1.54M-$600.0K-$779.0K
EPS (Diluted)$4.90$805.20$494.40$0.60
Total Assets$21.44M$5.55M$559.0Kn/a
Shareholders' Equity$20.99M$5.29M-$191.0K-$900.0K
Cash & Equivalents$1.31M$2.55M$4.0Kn/a
Operating Cash Flow-$4.53M-$1.15M-$537.0K-$1.13M
Capital Expenditures$7.0Kn/an/a$3.0K
Free Cash Flow-$4.54Mn/an/a-$1.14M
Shares Outstanding1.61M2.8Kn/an/a
Weighted Average Diluted Shares680.4K2.0K1.4K1.31M
EPS (Basic)$4.90$805.20$494.40$0.60

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView